Concepts (116)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prebiotics | 4 | 2023 | 24 | 1.330 |
Why?
|
| Dietary Fiber | 4 | 2023 | 25 | 1.320 |
Why?
|
| Gastrointestinal Microbiome | 8 | 2023 | 181 | 1.130 |
Why?
|
| Diet | 5 | 2023 | 220 | 0.700 |
Why?
|
| Defecation | 1 | 2017 | 5 | 0.570 |
Why?
|
| Starch | 1 | 2017 | 10 | 0.560 |
Why?
|
| Microspheres | 1 | 2017 | 24 | 0.560 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2017 | 88 | 0.520 |
Why?
|
| Dermatitis, Atopic | 3 | 2021 | 14 | 0.490 |
Why?
|
| Nutrition Therapy | 1 | 2012 | 8 | 0.410 |
Why?
|
| Dietetics | 1 | 2012 | 8 | 0.400 |
Why?
|
| Nutritional Support | 1 | 2012 | 25 | 0.400 |
Why?
|
| Professional Role | 1 | 2012 | 36 | 0.390 |
Why?
|
| Microbiota | 2 | 2023 | 104 | 0.390 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2012 | 117 | 0.360 |
Why?
|
| Food Hypersensitivity | 2 | 2021 | 40 | 0.330 |
Why?
|
| Surveys and Questionnaires | 4 | 2021 | 1216 | 0.320 |
Why?
|
| NF-kappa B | 3 | 2022 | 118 | 0.320 |
Why?
|
| Postoperative Complications | 1 | 2012 | 932 | 0.250 |
Why?
|
| Humans | 19 | 2023 | 28436 | 0.230 |
Why?
|
| Parkinson Disease | 2 | 2023 | 859 | 0.210 |
Why?
|
| Metabolic Syndrome | 1 | 2023 | 62 | 0.200 |
Why?
|
| Obesity | 4 | 2023 | 321 | 0.200 |
Why?
|
| beta-Glucans | 1 | 2022 | 24 | 0.200 |
Why?
|
| Fatty Acids, Volatile | 2 | 2023 | 35 | 0.190 |
Why?
|
| Feces | 2 | 2023 | 113 | 0.190 |
Why?
|
| Sleep | 2 | 2021 | 355 | 0.180 |
Why?
|
| Double-Blind Method | 2 | 2018 | 433 | 0.160 |
Why?
|
| Sodium, Dietary | 1 | 2019 | 7 | 0.160 |
Why?
|
| Feeding Behavior | 1 | 2019 | 92 | 0.160 |
Why?
|
| Sleep Wake Disorders | 1 | 2020 | 130 | 0.160 |
Why?
|
| Internet | 1 | 2019 | 98 | 0.150 |
Why?
|
| Sodium | 1 | 2019 | 64 | 0.150 |
Why?
|
| Bifidobacterium | 1 | 2018 | 2 | 0.150 |
Why?
|
| Synbiotics | 1 | 2018 | 2 | 0.150 |
Why?
|
| Tight Junctions | 1 | 2018 | 24 | 0.150 |
Why?
|
| Oligosaccharides | 1 | 2018 | 17 | 0.150 |
Why?
|
| Probiotics | 1 | 2018 | 19 | 0.150 |
Why?
|
| Diet, Mediterranean | 1 | 2019 | 101 | 0.150 |
Why?
|
| Gene Expression Regulation | 2 | 2011 | 281 | 0.140 |
Why?
|
| Circadian Rhythm | 1 | 2021 | 299 | 0.140 |
Why?
|
| Intestines | 1 | 2018 | 99 | 0.140 |
Why?
|
| Fermentation | 1 | 2017 | 12 | 0.140 |
Why?
|
| Constipation | 1 | 2017 | 19 | 0.140 |
Why?
|
| Gastrointestinal Tract | 1 | 2017 | 53 | 0.140 |
Why?
|
| Body Mass Index | 2 | 2021 | 465 | 0.130 |
Why?
|
| Adult | 4 | 2019 | 8107 | 0.130 |
Why?
|
| HIV Infections | 1 | 2020 | 488 | 0.120 |
Why?
|
| Gene-Environment Interaction | 1 | 2014 | 18 | 0.110 |
Why?
|
| Male | 7 | 2019 | 15291 | 0.110 |
Why?
|
| Female | 7 | 2019 | 15730 | 0.110 |
Why?
|
| Mucositis | 1 | 2012 | 5 | 0.100 |
Why?
|
| Chi-Square Distribution | 1 | 2012 | 146 | 0.100 |
Why?
|
| Certification | 1 | 2012 | 49 | 0.100 |
Why?
|
| Interprofessional Relations | 1 | 2012 | 43 | 0.100 |
Why?
|
| Apolipoprotein E4 | 1 | 2014 | 264 | 0.100 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2011 | 11 | 0.090 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2011 | 17 | 0.090 |
Why?
|
| RNA, Ribosomal, 16S | 2 | 2023 | 60 | 0.090 |
Why?
|
| Inflammation | 2 | 2023 | 284 | 0.090 |
Why?
|
| Middle Aged | 3 | 2019 | 9269 | 0.090 |
Why?
|
| Animals | 1 | 2017 | 3780 | 0.080 |
Why?
|
| Reproducibility of Results | 2 | 2023 | 737 | 0.080 |
Why?
|
| South Africa | 2 | 2018 | 13 | 0.080 |
Why?
|
| Nostoc commune | 1 | 2008 | 1 | 0.070 |
Why?
|
| Lipids | 1 | 2008 | 52 | 0.070 |
Why?
|
| Infant | 2 | 2021 | 587 | 0.070 |
Why?
|
| Macrophages | 1 | 2008 | 108 | 0.070 |
Why?
|
| Cognition Disorders | 1 | 2014 | 1003 | 0.070 |
Why?
|
| Child, Preschool | 2 | 2018 | 688 | 0.060 |
Why?
|
| Dysbiosis | 1 | 2023 | 56 | 0.050 |
Why?
|
| Prospective Studies | 2 | 2021 | 1809 | 0.050 |
Why?
|
| Syk Kinase | 1 | 2022 | 10 | 0.050 |
Why?
|
| Lectins, C-Type | 1 | 2022 | 46 | 0.050 |
Why?
|
| Phenotype | 1 | 2021 | 313 | 0.040 |
Why?
|
| Signal Transduction | 1 | 2022 | 447 | 0.040 |
Why?
|
| Nutrition Surveys | 1 | 2019 | 20 | 0.040 |
Why?
|
| Nutrition Assessment | 1 | 2019 | 44 | 0.040 |
Why?
|
| Mental Recall | 1 | 2019 | 63 | 0.040 |
Why?
|
| RNA, Messenger | 2 | 2011 | 308 | 0.040 |
Why?
|
| Sucrose | 1 | 2018 | 18 | 0.040 |
Why?
|
| Eating | 1 | 2019 | 59 | 0.040 |
Why?
|
| Patient Compliance | 1 | 2019 | 164 | 0.040 |
Why?
|
| Endotoxemia | 1 | 2018 | 27 | 0.040 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 933 | 0.040 |
Why?
|
| Child | 1 | 2021 | 1420 | 0.030 |
Why?
|
| Independent Living | 1 | 2019 | 318 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2017 | 440 | 0.030 |
Why?
|
| Aged | 2 | 2019 | 9277 | 0.030 |
Why?
|
| Alleles | 1 | 2014 | 221 | 0.030 |
Why?
|
| Overweight | 1 | 2014 | 75 | 0.030 |
Why?
|
| United States | 1 | 2019 | 2201 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2014 | 390 | 0.020 |
Why?
|
| Young Adult | 1 | 2018 | 2069 | 0.020 |
Why?
|
| Hep G2 Cells | 1 | 2011 | 2 | 0.020 |
Why?
|
| ATP Binding Cassette Transporter 1 | 1 | 2011 | 2 | 0.020 |
Why?
|
| Acetophenones | 1 | 2011 | 2 | 0.020 |
Why?
|
| Benzopyrans | 1 | 2011 | 9 | 0.020 |
Why?
|
| Protein Kinase C-delta | 1 | 2011 | 10 | 0.020 |
Why?
|
| Lipoproteins, HDL | 1 | 2011 | 24 | 0.020 |
Why?
|
| RNA Interference | 1 | 2011 | 36 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2011 | 79 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2011 | 148 | 0.020 |
Why?
|
| Intestine, Small | 1 | 2011 | 34 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2014 | 1384 | 0.020 |
Why?
|
| Neuropsychological Tests | 1 | 2014 | 1226 | 0.020 |
Why?
|
| Liver | 1 | 2011 | 160 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2014 | 1926 | 0.020 |
Why?
|
| Chromatography, Thin Layer | 1 | 2008 | 3 | 0.020 |
Why?
|
| Densitometry | 1 | 2008 | 9 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2008 | 120 | 0.020 |
Why?
|
| Lipopolysaccharides | 1 | 2008 | 115 | 0.020 |
Why?
|
| Risk Factors | 1 | 2014 | 2408 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2008 | 351 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2008 | 539 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2014 | 4857 | 0.010 |
Why?
|